Product
mRNA-2736
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
A Phase 1, Open-Label, Multicenter, Study of mRNA-2736 in Patients With Relapsed or Refractory Multiple MyelomaStatus: Withdrawn, Estimated PCD: 2026-05-27
1 clinical trial
1 indication